John Charles Thomas

EVP, GENERAL COUNSEL · KRYSTAL BIOTECH, INC. · CIK 0002114900

FILING MIX · LIFETIME25%/75%

BUYS

SELLS

TOTAL VALUE

$720.4K

COMPANIES

ACTIVE SINCE

May 2026

HOLDINGS NOW

6,500

AVG SELL PX

$329.58

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

No backtest data available for John Charles Thomas. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.

Holdings over time

KRYS · 6,500 shares · as of Jun 25, 2026

Trading cadence · quarterly flow

BUY ● SELL ●

2026

FLOW · 1 buys / 3 sellsCOVERAGE · 1 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
KRYS KRYSTAL BIOTECH, INC.	SALE EVP, General Counsel	1,000	—	—	6,500	Jun 25, 2026	Jun 26, 2026 ↗	View →
KRYS KRYSTAL BIOTECH, INC.	PURCHASE EVP, General Counsel	1,000	$179.25	$179.3K	1,000	Jun 25, 2026	Jun 26, 2026 ↗	View →
KRYS KRYSTAL BIOTECH, INC.	SALE10b5-1 10b5-1 plan	1,000	$347.27	$347.3K	0	Jun 25, 2026	Jun 26, 2026 ↗	View →
KRYS KRYSTAL BIOTECH, INC.	SALE10b5-1 10b5-1 plan	642	$302.03	$193.9K	0	May 26, 2026	May 27, 2026 ↗	View →

Other insiders · KRYS

Loading peer insiders…

About this filer

CIK 0002114900

ROLE

EVP, General Counsel

PRIMARY

KRYS

COMPANIES

ACTIVE SINCE

May 2026

MARKETPEEL · /INSIDER/0002114900DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

The morning brief, before the bell.